This inventor holds 2 USPTO granted patents and 1 published patent application and 2 EPO patents. Top assignees: Vascular Biogenetics Ltd., Vascular Biogenics Ltd.. Active years: 2015-2022.
Company Filing History:
Years Active: 2015-2022
Title: Richard Penson: Innovator in Tumor Treatment
Introduction
Richard Penson is a notable inventor based in Braintree, MA (US), recognized for his contributions to medical innovations, particularly in the field of tumor treatment. He holds 2 patents that focus on utilizing adenoviruses to combat tumor growth and neo-vascularization.
Latest Patents
Penson's latest patents include innovative treatment methods using adenoviruses. The first patent outlines methods for reducing or eliminating tumors by inhibiting neo-vascularization or angiogenesis in patients. This is achieved by administering an adenovirus that contains a nucleic acid construct with a FAS-chimera gene linked to an endothelial cell-specific promoter. Additionally, he has developed a homogeneous population of this adenovirus for therapeutic use. The second patent reiterates similar methods and applications, emphasizing the potential of the FAS-chimera adenovirus vector in tumor treatment.
Career Highlights
Throughout his career, Richard Penson has worked with companies such as Vascular Biogenics Ltd. and Vascular Biogenetics Ltd. His work in these organizations has contributed significantly to advancements in vascular biology and cancer treatment methodologies.
Collaborations
Penson has collaborated with notable professionals in his field, including Eyal Breitbart and Andrea Leubitz. These collaborations have likely enhanced the development and application of his innovative treatment methods.
Conclusion
Richard Penson's work in developing adenovirus-based treatments for tumors showcases his commitment to advancing medical science. His patents reflect significant potential in improving cancer therapies and patient outcomes.